Cargando…

Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice

BACKGROUND: Body fluids such as saliva and tears from patients with hepatitis B virus (HBV) infection are known as infectious agents. The infectivity of feces from patients with HBV infection has not been established. The aim of this study was to determine whether feces from HBV carriers can be a so...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Haruki, Inui, Ayano, Murano, Takeyoshi, Tsunoda, Tomoyuki, Sogo, Tsuyoshi, Fujisawa, Tomoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545881/
https://www.ncbi.nlm.nih.gov/pubmed/26289533
http://dx.doi.org/10.1186/s13104-015-1337-z
_version_ 1782386805234991104
author Komatsu, Haruki
Inui, Ayano
Murano, Takeyoshi
Tsunoda, Tomoyuki
Sogo, Tsuyoshi
Fujisawa, Tomoo
author_facet Komatsu, Haruki
Inui, Ayano
Murano, Takeyoshi
Tsunoda, Tomoyuki
Sogo, Tsuyoshi
Fujisawa, Tomoo
author_sort Komatsu, Haruki
collection PubMed
description BACKGROUND: Body fluids such as saliva and tears from patients with hepatitis B virus (HBV) infection are known as infectious agents. The infectivity of feces from patients with HBV infection has not been established. The aim of this study was to determine whether feces from HBV carriers can be a source of HBV infection. METHODS: Thirty-three children and 17 adults (ages 0–49 years, median age 13 years) who were chronically infected with HBV were enrolled. The levels of HBV DNA in the feces from these patients were quantified by real-time PCR, and the levels of fecal HBsAg were measured. Isolated human hepatocytes from chimeric mice with humanized livers were co-cultured with serum, tears and feces from the HBV carriers. Four chimeric mice were inoculated intravenously with sterilized feces from HBV carriers. RESULTS: HBV DNA was detected in the feces of 37 (74 %) of the 50 patients. The fecal HBV DNA levels ranged from 2.8 to 8.4 log copies/mL (mean ± SD  =  5.6 ± 1.2 log copies/mL). A significant correlation was observed in the levels of HBV DNA between serum and feces (r  =  0.54, p < 0.05). Of the 13 HBV carries, 7 (54 %) were positive for fecal HBsAg. The fecal HBsAg levels ranged from 0.06 to 1.0 IU/mL (median 0.28 IU/mL). Immunogold electron microscopy showed Dane particles in feces. HBV DNA was detected in the human hepatocytes co-cultured with serum and tears, but not in those co-cultured with feces. HBV DNA was not detected in the serum of the chimeric mice after oral or intravenous inoculation with sterilized fecal samples, which contained 5 log copies/mL of HBV DNA levels. CONCLUSIONS: Although the positive rate of fecal HBV DNA was high, the fecal HBsAg levels were extremely low. The chimeric mice were not infected with HBV after oral or intravenous inoculation with sterilized fecal samples. Therefore, feces from HBV carriers seem not to serve as an infectious vehicle for the transmission of HBV.
format Online
Article
Text
id pubmed-4545881
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45458812015-08-23 Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice Komatsu, Haruki Inui, Ayano Murano, Takeyoshi Tsunoda, Tomoyuki Sogo, Tsuyoshi Fujisawa, Tomoo BMC Res Notes Research Article BACKGROUND: Body fluids such as saliva and tears from patients with hepatitis B virus (HBV) infection are known as infectious agents. The infectivity of feces from patients with HBV infection has not been established. The aim of this study was to determine whether feces from HBV carriers can be a source of HBV infection. METHODS: Thirty-three children and 17 adults (ages 0–49 years, median age 13 years) who were chronically infected with HBV were enrolled. The levels of HBV DNA in the feces from these patients were quantified by real-time PCR, and the levels of fecal HBsAg were measured. Isolated human hepatocytes from chimeric mice with humanized livers were co-cultured with serum, tears and feces from the HBV carriers. Four chimeric mice were inoculated intravenously with sterilized feces from HBV carriers. RESULTS: HBV DNA was detected in the feces of 37 (74 %) of the 50 patients. The fecal HBV DNA levels ranged from 2.8 to 8.4 log copies/mL (mean ± SD  =  5.6 ± 1.2 log copies/mL). A significant correlation was observed in the levels of HBV DNA between serum and feces (r  =  0.54, p < 0.05). Of the 13 HBV carries, 7 (54 %) were positive for fecal HBsAg. The fecal HBsAg levels ranged from 0.06 to 1.0 IU/mL (median 0.28 IU/mL). Immunogold electron microscopy showed Dane particles in feces. HBV DNA was detected in the human hepatocytes co-cultured with serum and tears, but not in those co-cultured with feces. HBV DNA was not detected in the serum of the chimeric mice after oral or intravenous inoculation with sterilized fecal samples, which contained 5 log copies/mL of HBV DNA levels. CONCLUSIONS: Although the positive rate of fecal HBV DNA was high, the fecal HBsAg levels were extremely low. The chimeric mice were not infected with HBV after oral or intravenous inoculation with sterilized fecal samples. Therefore, feces from HBV carriers seem not to serve as an infectious vehicle for the transmission of HBV. BioMed Central 2015-08-20 /pmc/articles/PMC4545881/ /pubmed/26289533 http://dx.doi.org/10.1186/s13104-015-1337-z Text en © Komatsu et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Komatsu, Haruki
Inui, Ayano
Murano, Takeyoshi
Tsunoda, Tomoyuki
Sogo, Tsuyoshi
Fujisawa, Tomoo
Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
title Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
title_full Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
title_fullStr Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
title_full_unstemmed Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
title_short Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice
title_sort lack of infectivity of hbv in feces from patients with chronic hepatitis b virus infection, and infection using chimeric mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545881/
https://www.ncbi.nlm.nih.gov/pubmed/26289533
http://dx.doi.org/10.1186/s13104-015-1337-z
work_keys_str_mv AT komatsuharuki lackofinfectivityofhbvinfecesfrompatientswithchronichepatitisbvirusinfectionandinfectionusingchimericmice
AT inuiayano lackofinfectivityofhbvinfecesfrompatientswithchronichepatitisbvirusinfectionandinfectionusingchimericmice
AT muranotakeyoshi lackofinfectivityofhbvinfecesfrompatientswithchronichepatitisbvirusinfectionandinfectionusingchimericmice
AT tsunodatomoyuki lackofinfectivityofhbvinfecesfrompatientswithchronichepatitisbvirusinfectionandinfectionusingchimericmice
AT sogotsuyoshi lackofinfectivityofhbvinfecesfrompatientswithchronichepatitisbvirusinfectionandinfectionusingchimericmice
AT fujisawatomoo lackofinfectivityofhbvinfecesfrompatientswithchronichepatitisbvirusinfectionandinfectionusingchimericmice